MALAT1: A long non-coding RNA highly associated with human cancers (Review)

被引:108
作者
Zhao, Miaomiao [1 ,2 ]
Wang, Songpo [1 ]
Li, Qi [3 ]
Ji, Qing [3 ]
Guo, Piaoting [1 ]
Liu, Xiaowei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Tradit Chinese Med, 100 Haining Rd, Shanghai 200080, Peoples R China
[2] Zhengzhou Tradit Chinese Med Hosp, Dept Oncol, Zhengzhou 450007, Henan, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Oncol, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
long non-coding RNA; metastasis-associated lung adenocarcinoma transcript 1; cancer; clinical application; molecular mechanism; ADENOCARCINOMA TRANSCRIPT 1; SQUAMOUS-CELL CARCINOMA; LNCRNA MALAT1; UP-REGULATION; MESENCHYMAL TRANSITION; MALIGNANT PHENOTYPES; OSTEOSARCOMA CELLS; COLORECTAL-CANCER; REGULATORY ROLE; POOR-PROGNOSIS;
D O I
10.3892/ol.2018.8613
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a well-known lncRNA associated with numerous diseases, particularly cancer, has received increased attention. The expression of MALAT1 was determined to be upregulated in numerous types of tumors and MALAT1 exhibited effects on tumor cell proliferation, migration, invasion and apoptosis. The abnormal expression of MALAT1 was identified in almost in every organ of the digestive system. MALAT1 performed an important role in the pathological alterations of organs that are associated with sex hormones and several reproductive system cancers. MALAT1 participates in molecular pathways. In the clinical application of MALAT1, MALAT1 was considered as a potential biomarker for the diagnosis and prediction of cancers, and may also serve as therapeutic target for treatment of specific tumors. This review summarizes the abnormal expression of MALAT1 in cancer, its significant effect on the primary features of cancer, as well as the underlying molecular mechanisms of MALAT1 in various cancers. According to studies on MALAT1, we introduce the upstream and downstream substances associated with the function of MALAT1. These reviewed studies promote the clinical application of MALAT1 in the aspect of diagnosis and treatment of different cancers, and may help point out new study directions for MALAT1.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 89 条
[1]  
[Anonymous], TUMOUR BIOL
[2]   Cisplatin and paclitaxel target significant long noncoding RNAs in laryngeal squamous cell carcinoma [J].
Chen, Hui ;
Xin, Yuan ;
Zhou, Liang ;
Huang, Jia-meng ;
Tao, Lei ;
Cheng, Lei ;
Tian, Jie .
MEDICAL ONCOLOGY, 2014, 31 (11)
[3]   MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression [J].
Cho, Shih-Feng ;
Chang, Yuli Christine ;
Chang, Chao-Sung ;
Lin, Sheng-Fung ;
Liu, Yi-Chang ;
Hsiao, Hui-Hua ;
Chang, Jan-Gowth ;
Liu, Ta-Chih .
BMC CANCER, 2014, 14
[4]   Landscape of transcription in human cells [J].
Djebali, Sarah ;
Davis, Carrie A. ;
Merkel, Angelika ;
Dobin, Alex ;
Lassmann, Timo ;
Mortazavi, Ali ;
Tanzer, Andrea ;
Lagarde, Julien ;
Lin, Wei ;
Schlesinger, Felix ;
Xue, Chenghai ;
Marinov, Georgi K. ;
Khatun, Jainab ;
Williams, Brian A. ;
Zaleski, Chris ;
Rozowsky, Joel ;
Roeder, Maik ;
Kokocinski, Felix ;
Abdelhamid, Rehab F. ;
Alioto, Tyler ;
Antoshechkin, Igor ;
Baer, Michael T. ;
Bar, Nadav S. ;
Batut, Philippe ;
Bell, Kimberly ;
Bell, Ian ;
Chakrabortty, Sudipto ;
Chen, Xian ;
Chrast, Jacqueline ;
Curado, Joao ;
Derrien, Thomas ;
Drenkow, Jorg ;
Dumais, Erica ;
Dumais, Jacqueline ;
Duttagupta, Radha ;
Falconnet, Emilie ;
Fastuca, Meagan ;
Fejes-Toth, Kata ;
Ferreira, Pedro ;
Foissac, Sylvain ;
Fullwood, Melissa J. ;
Gao, Hui ;
Gonzalez, David ;
Gordon, Assaf ;
Gunawardena, Harsha ;
Howald, Cedric ;
Jha, Sonali ;
Johnson, Rory ;
Kapranov, Philipp ;
King, Brandon .
NATURE, 2012, 489 (7414) :101-108
[5]   MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway [J].
Dong, Yongqiang ;
Liang, Guojun ;
Yuan, Bo ;
Yang, Chaoqun ;
Gao, Rui ;
Zhou, Xuhui .
TUMOR BIOLOGY, 2015, 36 (03) :1477-1486
[6]   Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development [J].
Eissmann, Moritz ;
Gutschner, Tony ;
Haemmerle, Monika ;
Guenther, Stefan ;
Caudron-Herger, Maiwen ;
Gross, Matthias ;
Schirmacher, Peter ;
Rippe, Karsten ;
Braun, Thomas ;
Zoernig, Martin ;
Diederichs, Sven .
RNA BIOLOGY, 2012, 9 (08) :1076-1087
[7]   TGF-β-Induced Upregulation of malat1 Promotes Bladder Cancer Metastasis by Associating with suz12 [J].
Fan, Yu ;
Shen, Bing ;
Tan, Mingyue ;
Mu, Xinyu ;
Qin, Yan ;
Zhang, Fang ;
Liu, Yong .
CLINICAL CANCER RESEARCH, 2014, 20 (06) :1531-1541
[8]   Prognostic significance of drug-regulated genes in high-grade osteosarcoma [J].
Fellenberg, Joerg ;
Bernd, Ludger ;
Delling, Guenter ;
Witte, Daniela ;
Zahlten-Hinguranage, Anita .
MODERN PATHOLOGY, 2007, 20 (10) :1085-1094
[9]   The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator [J].
Feng, Jianchi ;
Bi, Chumming ;
Clark, Brian S. ;
Mady, Rina ;
Shah, Palak ;
Kohtz, Jhumku D. .
GENES & DEVELOPMENT, 2006, 20 (11) :1470-1484
[10]   Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637 [J].
Fu, Xing ;
Liu, Yuchen ;
Zhuang, Chengle ;
Liu, Li ;
Cai, Zhiming ;
Huang, Weiren .
MOLECULAR BIOSYSTEMS, 2015, 11 (05) :1285-1289